Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis

Journal of Arthroplasty

Volumn 14, Issue 4, 1999, Pages 432-438

  Shaieb, Mark D ^a   Watson, Brandi N ^a   Atkinson, Robert E ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Complications; Enoxaparin; Low molecular weight heparin; Thromboprophylaxis; Total hip arthroplasty; Total knee arthroplasty

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EPIDURAL CATHETER; EPIDURAL HEMATOMA; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 0032798145     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-5403(99)90098-0     Document Type: Article

References (29)

1. Carter CJ, Kelton JG, Hirsh J, et al: The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 59:1239, 1982
2. Fernandez F, Nguyen P, Van Ryn J, et al: Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res 43:491, 1986
3. Ockelford PA, Carter CJ, Cerskus A, et al: Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin III affinity heparin fraction. Thromb Res 27:679, 1982
4. Salzman EW, Rosenberg RD, Smith MH, et al: Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64, 1980
5. Dawes J, Bara L, Billaud E, Samama M: Relationship between biological activity and concentration of a low molecular weight heparin (PK-10169) and unfractionated heparin after intravenous and subcutaneous administration. Haemostasis 16:116, 1986
6. Aiach M, Michaud A, Balian JL: A new low molecular weight heparin derivative: in vitro and in vivo studies. Thromb Res 31:611, 1983
7. Brace LD, Fareed J, Tomeo J, Issleib S: Biochemical and pharmacological studies on the interaction of PK-10169 and its subfractions with human-platelets. Haemostasis 16:93, 1986
8. Cade JF, Buchanan MR, Boneu BA: A comparison of the anti-thrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 35:613, 1984
9. Hirsh J, Levine MN: Low molecular weight heparins. Blood 79:1, 1992
10. Aiach M, Roncato M: Practical considerations on the measurements of low molecular weight heparin and anti-Xa activity. Semin Thromb Haemost 11:108, 1985
11. Vinazzer H, Woler MA: A new molecular weight heparin fragment (PK 10169): in vitro and in vivo studies. Haemostasis 16:106, 1986
12. Walenga JM, Fareed J, Hoppensteadt D: In vitro coagulant and amidolytic methods for evaluation of the activity of heparin and a low molecular weight heparin derivative (PK-10169). Semin Thromb Haemost 11:17, 1985
13. Hull R, Raskob G, Peneo G, et al: A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 329:1370, 1993
14. RD Heparin Arthroplasty Group: RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am 76:1174, 1994
15. Leclerc JR, Geerts WH, Desjardins L, et al: Prevention of venous thromboembolism after knee arthroplasty: a randomized double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 124:619, 1996
16. Cola C, Ansell J: Heparin-induced thrombocytopenia and arterial thrombosis, alternative therapies. Am Heart J 119:368, 1990
17. Colwell CW, Spiro TE, Trowbridge AA, et al: Use of enoxaparin a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. J Bone Joint Surg Am 76:3, 1994
18. Imperiale TF, Speroff T: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 271:1780, 1994
19. Barsotti J, Gruel Y, Rosset P, et al: Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma 4:371, 1990
20. Bergqvist D, Benoni G, Bjorgell O, et al: Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 335:696, 1996
21. Colwell CW, Spiro TE: Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty. Clin Orthop 319:215, 1995
22. Turpie AG, Levine MN, Hirsh J, et al: A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315:925, 1986
23. Warwick D, Bannister GC, Glew D, et al: Perioperative low-molecular-weight heparin. J Bone Joint Surg Br 77:715, 1995
24. Colwell CW, Spiro TE, Trowbridge AA, et al: Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Clin Orthop 321:19, 1995
25. Leclerc JR, Geerts WH, Desjardins L, et al: Prevention of deep vein thrombosis after major knee surgery - a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 67:417, 1992
26. Sternlo JE, Hybbinette CH: Spinal subdural bleeding after attempted epidural and subsequent spinal anaesthesia in a patient on thromboprophylaxis with low molecular weight heparin. Acta Anaesthesiol Scand 39:557, 1995
27. Choquet O, Krivosic-Horber R, Delecroix M, et al: Hamatome sousarachnoiden apres rachianesthesie et heparine de bas poids moleculaire. Ann Fr Anesth Reanim 12:428, 1993
28. Hynson JM, Katz JA, Bueff HU: Epidural hematoma associated with enoxaparin. Anesth Analg 82:1072, 1996
29. Tryba M, Biscoping J, von Bormann B, et al: Hamostaseologische Voraussetzungen zur Durchfuhrung von Regionalanaesthesien. Reg Anest 12:127, 1989